Alto Neuroscience, Inc. (ANRO)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 85.01M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 15.04
52W Low
$ 1.60
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
2.6974
200-Day MA
3.2104
52 Week High
15.04
52 Week Low
1.6
About ANRO
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States.
Employees
76
Headquarters
Mountain View, CA
CEO
Dr. Amit Etkin M.D., Ph.D.
Latest News
New Analyst Forecast: $ANRO Given $10.0 Price Target - Quiver Quantitative
Yesterday • Google News
SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A - GlobeNewswire
Yesterday • Google News